Home > Inhibitors & Agonists > Tyrosine Kinase > RET Tyrosine Kinase (c-RET)
Cat. No. Product name CAS No.
DC10633 AD80

AD80, a multikinase inhibitor, shows strong activity against human RET, BRAF, S6K, and SRC but were much less active than either AD57 or AD58 against mTOR. The IC50 value for RET is 4 nM.

1384071-99-1
DC10058 BBT594

BBT594 (NVP-BBT594), is potent and selective inhibitor of RET and JAK2.

882405-89-2
DC11479 BLU-667 (Pralsetinib) Featured

BLU-667 (Pralsetinib) is a highly potent, selective, next generation RET inhibitor with IC50 of 0.3-0.4 nM for WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET fusion.

2097132-94-8
DC10936 GSK3179106 Featured

GSK3179106 (GSK-3179106, GSK 3179106) is a potent, selective, first-in-class and gut-restricted with IC50 of 0.4 and 11 nM in the biochemical assay and cellular assay respectively.

1627856-64-7
DC7763 NVP-AST487

NVP-AST487 is a RET kinase inhibitor/FLT3 inhibitor.

630124-46-8
DC11450 Selpercatinib(LOXO-292) Featured

Selpercatinib is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 163, has an IC50 of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M) , and RET (G810R), respectively. Antineoplastic activity.

2152628-33-4
Page 1 / Total 1 FirstPrevNextLastGoto